Published: July 24, 2026
India’s primary market is set to witness another major public issue as Manipal Health Enterprises prepares to launch its ₹9,275 crore Initial Public Offering (IPO) on July 29, 2026. The IPO is expected to be one of the biggest healthcare public offerings of the year, attracting strong interest from retail as well as institutional investors.
The company has announced a price band of ₹560 to ₹590 per share. With India’s healthcare sector continuing to expand rapidly, market experts believe the IPO could receive significant attention from investors looking for long-term growth opportunities.
Manipal Health IPO: Key Highlights
| Particulars | Details |
|---|---|
| IPO Opening Date | July 29, 2026 |
| IPO Closing Date | July 31, 2026 |
| Issue Size | ₹9,275 Crore |
| Price Band | ₹560 – ₹590 per share |
| Face Value | ₹10 per share |
| Listing | BSE & NSE |
| Industry | Healthcare / Hospitals |
About Manipal Health Enterprises
Manipal Health Enterprises is one of India’s leading multi-specialty hospital chains, offering advanced healthcare services across multiple cities. The company operates a wide network of hospitals equipped with modern medical technology and experienced healthcare professionals.
Its major healthcare services include:
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Organ Transplants
- Emergency & Critical Care
- Multi-Specialty Hospital Services
The company’s strong brand presence and expanding hospital network have made it one of the most recognized names in India’s healthcare sector.
Grey Market Premium (GMP)
Investors are closely tracking the Grey Market Premium (GMP) ahead of the IPO launch.
Market analysts suggest that GMP may fluctuate daily based on investor sentiment. However, they also advise investors not to rely solely on GMP while making investment decisions, as it is an unofficial market indicator and does not guarantee listing performance.
How Will the IPO Proceeds Be Used?
According to the company, the funds raised through the IPO are expected to be utilized for:
- Expanding hospital infrastructure
- Setting up new healthcare facilities
- Investing in advanced medical equipment
- Debt reduction
- General corporate purposes
These investments are expected to strengthen the company’s long-term growth strategy.
Should You Invest?
Financial experts believe India’s healthcare industry offers strong long-term growth potential. However, before investing in any IPO, investors should carefully evaluate:
- Company’s financial performance
- Revenue and profit growth
- Industry outlook
- Valuation
- Risk factors
- Long-term business strategy
Experts recommend reading the company’s Red Herring Prospectus (RHP) before making any investment decision.
Important Points for Investors
Before applying for the IPO, investors should:
- Read the official IPO prospectus.
- Avoid making decisions based only on GMP.
- Assess their risk appetite.
- Maintain a diversified investment portfolio.
- Consult a financial advisor if required.
Market Outlook
The healthcare sector has remained one of India’s fastest-growing industries over the past few years. With increasing healthcare demand, expanding hospital infrastructure, and rising medical investments, analysts believe the sector could continue to perform well over the long term.
If market conditions remain stable, Manipal Health IPO is expected to attract healthy participation from both retail and institutional investors.
Conclusion
The Manipal Health IPO is among the most anticipated public offerings of 2026. Backed by a strong healthcare brand, an extensive hospital network, and growth opportunities in India’s healthcare sector, the IPO has generated considerable market interest. However, investors should conduct proper research and evaluate all risks before investing.
FAQs
Q1. When will the Manipal Health IPO open?
The IPO will open for subscription on July 29, 2026.
Q2. What is the price band of the IPO?
The price band has been fixed at ₹560 to ₹590 per share.
Q3. What is the total IPO size?
The IPO size is ₹9,275 crore.
Q4. Which stock exchanges will list the IPO?
The shares are expected to be listed on both the BSE and NSE.
Q5. Should investors rely only on GMP?
No. GMP is an unofficial indicator. Investors should also evaluate the company’s financials, business prospects, and risk factors before investing.
